-
TriVascular trials progress in Europe
March 29th, 2010SANTA ROSA — TriVascular’s abdominal stent graft is showing solid results in European clinical trials, well on its way to holding a leading position in a predicted $2 billion global market.
Lists Online
NBBJ Insider blog- Occupy Santa Rosa vs. Exchange Bank: The wrong target December 9, 2011
Top News-
Most popular recent items
- Bulk-wine inventory hits 12-year low 7991 view(s) | posted on January 19, 2012
- Forecast: Wine, grape prices to rise in 2012 3382 view(s) | posted on January 25, 2012
- Horizon to add San Diego flights; Vegas out 2396 view(s) | posted on January 18, 2012
Latest reader comments
Lary Kirchenbauer columns- An error has occurred; the feed is probably down. Try again later.
Previous articles
Business Journal connections








Mobile